Markers of the progression of complications in patients with type 2 diabetes: a one-year longitudinal study

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association

Volumn 122, Issue 8, 2014, Pages 484-490

  Preciado Puga, M C ^a   Malacara, J M ^a   Fajardo Araujo, M E ^a   Wrobel K ^a   Kornhauser Araujo, C ^a   Garay Sevilla, M E ^a  

^a UNIVERSITY OF GUANAJUATO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; INTERLEUKIN 6; LIPID; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANALYSIS; BLOOD; COMPLICATION; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE COURSE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LONGITUDINAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; DISEASE PROGRESSION; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INTERLEUKIN-6; LIPIDS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84929938547     PISSN: None     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0034-1372594     Document Type: Article

References (0)